[1]
Yousefi, F. et al. 2023. The Effects of Selective Serotonin Reuptake Inhibitors on Neurological and Depressive Symptoms in Multiple Sclerosis: A Systematic Review and Meta‐analysis of Randomized Controlled Trials: SSRIs in Multiple Sclerosis: Meta-analysis: SSRIs in Multiple Sclerosis: Meta-analysis. Galen Medical Journal. 12, (Dec. 2023), e3153. DOI:https://doi.org/10.31661/gmj.v12i.3153.